Genentech Announces FDA Approval of Xofluza(Baloxavir Marboxil) to Treat Influenza in Children Aged Five and Older
Summary: Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved for children as young…
Summary: Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved for children as young…
FDA approved Genentech’s Susvimo, a port delivery system with a customized formulation of Ranibizumab, the active ingredient in Lucentis. Now, the trick for…